CMBT Q1 2026: Firing on All Cylinders, but Leverage Still the Wild Card

What happened

CMB.TECH reported Q1 2026 results with a bullish 'firing on all cylinders' headline, yet the actual numbers are absent from the release. Given the trajectory from Q3 2025—revenue of $454M, EBITDA of $238M, net income of $19.9M—Q1 likely continued the trend of top-line growth from fleet expansion and strong TCEs, but net profit remained compressed by elevated finance costs (Q3 net finance expense $111M) and lower capital gains versus the prior year. The stock's 22% run to $13 since a year ago reflects market optimism on backlog conversion and ammonia milestones, but with net debt/EBITDA at 4.8x and interest coverage at 4.5x, any earnings miss or project delay could reverse the rally. The lack of detailed disclosure in this announcement keeps the balance-sheet risk front and center.

Implication

The 'firing on all cylinders' narrative is premature: absent hard numbers, the market is pricing in execution perfection. Investors should demand proof that EBITDA growth is outpacing finance costs and that leverage is stabilizing. A pullback toward $11 remains the more attractive entry, and Q1 details should be scrutinized for cash flow, debt trends, and ammonia milestones before adding exposure.

Thesis delta

The Q1 announcement is consistent with the existing WAIT thesis: strong operating trends continue, but the report provides no evidence of deleveraging or earnings quality improvement. The thesis remains unchanged—await either a pullback to $11 or concrete proof of leverage stabilizing below 4x net debt/EBITDA before upgrading.